Chemotherapy plus Ofatumumab at Standard or Mega dose In Chronic lymphoid leukemia (CLL)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Ofatumumab (Primary) ; Bendamustine; Cyclophosphamide; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Acronyms COSMIC
- 25 Jun 2017 Primary endpoint (Proportion of patients achieving a Complete Response) has not been met, according to the abstract presented at the 22nd Congress of the European Haematology Association.
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association.
- 20 Sep 2016 Status changed to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History